文献速递前列腺癌

多参数磁共振成像在初诊未活检男性中的前列腺癌检测效能:前瞻性研究的荟萃分析

Performance of Multiparametric MRI of the Prostate in Biopsy Naïve Men: A Meta-analysis of Prospective Studies.
PubMed 文献 · Urology · 2020-09-02

该荟萃分析纳入10项前瞻性研究共2486例初诊未活检男性,评估多参数磁共振成像(mpMRI)检测前列腺癌(PCa)和临床显著前列腺癌(csPCa)的效能。结果显示mpMRI对任何PCa的合并敏感度0.86、特异度0.67,对csPCa的合并敏感度0.94、特异度0.54;若仅对mpMRI可疑者活检,可避免7.4%-58.5%的活检,但会漏诊2.3%-36%的任何PCa和0%-30.8%的csPCa。

要点

  • mpMRI对csPCa的合并敏感度达0.94,阴性似然比0.1,阴性时漏诊风险低。
  • 仅对mpMRI可疑者活检可避免7.4%-58.5%的活检,但可能漏诊部分PCa。
  • mpMRI对任何PCa的AUC为0.84,对csPCa的AUC为0.94。

核心结论

  • mpMRI能准确检测前列腺癌,并有助于在该人群中避免不必要的活检。

研究设计与样本

  • 系统综述与荟萃分析,纳入10项前瞻性研究,共2486例初诊未活检男性,评估mpMRI在活检时检测PCa的效能。

主要发现

  • 若仅对mpMRI可疑恶性者进行活检,可避免7.4%-58.5%的活检,但会漏诊2.3%-36%的任何PCa和0%-30.8%的csPCa。
  • mpMRI检测任何PCa的合并敏感度0.86(95%CI 0.78-0.91)、特异度0.67(95%CI 0.40-0.86)、阳性似然比2.6(95%CI 1.2-5.5)、阴性似然比0.2(95%CI 0.12-0.32),AUC 0.84(95%CI 0.75-0.90)。
  • mpMRI检测csPCa的合并敏感度0.94(95%CI 0.83-0.98)、特异度0.54(95%CI 0.42-0.65)、阳性似然比2(95%CI 1.5-2.7)、阴性似然比0.1(95%CI 0.02-0.35),AUC 0.94(95%CI 0.65-1)。

关键数值与推荐

  • mpMRI检测任何PCa的合并敏感度0.86(95%CI 0.78-0.91),特异度0.67(95%CI 0.40-0.86)。
  • mpMRI检测csPCa的合并敏感度0.94(95%CI 0.83-0.98),特异度0.54(95%CI 0.42-0.65)。
  • 仅对mpMRI可疑者活检可避免7.4%-58.5%的活检,但漏诊2.3%-36%的任何PCa和0%-30.8%的csPCa。

临床怎么用

  • 在初诊未活检男性中,mpMRI阴性(尤其针对csPCa)可支持暂缓活检,但需结合个体情况权衡漏诊风险。
  • mpMRI可疑者应进行靶向活检,以避免遗漏临床显著前列腺癌。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the outcomes through systematic review and meta-analysis of multi-parametric magnetic resonance imaging (mpMRI) of the prostate in biopsy naïve men. METHODS: Systemic review and meta-analysis was performed to assess the performance of mpMRI on prostate cancer (PCa) detection at the time of biopsy. We used standard methods for performing a meta-analysis evaluating a diagnostic test and reported the pooled sensitivity and specificity, and the positive and negative likelihood ratios (LR) for mpMRI in the detection of any and clinically significant prostate cancer (csPCa). RESULTS: A total of 10 studies comprising 2486 patients were analyzed. Overall, if biopsies would have been performed only in men with an mpMRI suspicious for malignancy between 7.4% and 58.5% of the biopsies could have been avoided, but 2.3%-36% of any PCa and 0%-30.8% of csPCa would have been missed. The sensitivity, specificity, positive LR, and negative LR of mpMRI for any PCa detection were 0.86 (95% confidence interval [CI], 0.78-0.91), 0.67 (95% CI, 0.40-0.86), 2.6 (95% CI, 1.2-5.5), and 0.2 (95% CI, 0.12-0.32), respectively. The AUC for any PCa detection was 0.84 (95% CI, 0.75-0.90). The pooled sensitivity, specificity, positive LR, and negative LR of mpMRI for csPCa detection was 0.94 (95% CI, 0.83-0.98), 0.54 (95% CI, 0.42-0.65), 2 (95% CI, 1.5-2.7), and 0.1 (95% CI, 0.02-0.35), respectively. The AUC for csPCa detection was 0.94 (95% CI, 0.65-1). CONCLUSION: This study provides summary estimates indicating that mpMRI can accurately detect prostate cancer and help avoid unnecessary biopsies in this population.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Becerra MF, Alameddine M, Zucker I, et al. Performance of Multiparametric MRI of the Prostate in Biopsy Naïve Men: A Meta-analysis of Prospective Studies. Urology. 2020. PMID: 32890616. doi:10.1016/j.urology.2020.06.102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。